Research Studies

Peanut Oral Immunotherapy Trial for People Over 16 Years

St Vincent’s Hospital Sydney is recruiting to an Australia-first research trial to help people over 16 years of age, who are living with peanut allergy. We are investigating the effectiveness of combining omalizumab with peanut oral immunotherapy in improving safety and tolerability of peanut immunotherapy in adults. This will not cure peanut allergy, but aims to improve safety and quality of life for those living with peanut allergy into adulthood.

We are seeking participants who are:
-           over the age of 16 and have peanut allergy
-           have not been admitted to ICU for a peanut reaction in the last 5 years
-           not lactating, pregnant or planning pregnancy 
-           and able to commit to 18 study visits over 12 months (7 of the visits take between 4 to 6 hours) 

Prospective participants and their referrers can contact us by email at This email address is being protected from spambots. You need JavaScript enabled to view it.. Include your phone number and the best time for a member of the study team to contact you. Information can also be found at https://www.svhs.org.au/research-education/participating-in-research-trials/peanut-allergy-immunotherapy-trial

Participants will be reimbursed for travel (e.g. taxi fares) and parking costs associated with study visits. Please note that all visits will be occurring at St Vincent’s Public Hospital Sydney.

This study has been approved by South West Sydney Local Health District Human Research Ethics Committee. Reference number 2019/ETH13494 and recruitment will end in November 2021.

We would like to acknowledge The Balnaves Foundation, St Vincent’s Curran Foundation and SPHERE Triple I for their support of this study. 

Allergy and Immunology Foundation of Australasia (AIFA)

AIFA - ACNC Registered Charity OrganisationAIFA was established in 2013 by ASCIA to fund medical research into allergy and other immune diseases. Donate to AIFA at www.allergyimmunology.org.au/donate  

To apply for an AIFA research grant the Chief Investigator must be an ASCIA member. Download an Expression of Interest form at www.allergyimmunology.org.au/grants  

For information about research projects funded by AIFA grants go to www.allergyimmunology.org.au/projects 

Content updated March 2021

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.